InsiderDB

Lobbying disclosures · Lobbying report

CL: second_quarter 2026 lobbying report

FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products

Follow CL
Became public
Jul 18, 2026, 10:50 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 4:28 AM EST

Why this is connected

Legal-name match: COLGATE-PALMOLIVE COMPANY is COLGATE PALMOLIVE CO (https://www.sec.gov/Archives/edgar/data/21665/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/8242d0df-dd37-4329-97d3-12b2bbb96545/","filing_uuid":"8242d0df-dd37-4329-97d3-12b2bbb96545","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/8242d0df-dd37-4329-97d3-12b2bbb96545/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Alisa Hess","dt_posted":"2026-07-18T22:50:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 North Capitol Street, NW","registrant_address_2":"Suite 210","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":1171,"url":"https://lda.gov/api/v1/registrants/1171/","house_registrant_id":31749,"name":"ALPINE GROUP PARTNERS, LLC.","description":"Public relations consulting firm","address_1":"500 North Capitol Street, NW","address_2":"Suite 210","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISA JANE HESS","contact_telephone":"+1 434-933-2535","dt_updated":"2026-08-19T14:46:16.762025-04:00"},"client":{"id":69625,"url":"https://lda.gov/api/v1/clients/69625/","client_id":69625,"name":"COLGATE-PALMOLIVE COMPANY","general_description":"A consumer and household products company","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-10-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149082,"prefix":null,"prefix_display":null,"first_name":"COLIN","nickname":null,"middle_name":null,"last_name":"BRAINARD","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Rep. Steve Watkins; Executive Director, Joint Economic Cmte.; Dep. Chief of Staff, Rep. Erik Paulsen; Dep. Chief of Staff, Rep. Lynn Jenkins; LC, Sen. Richard Burr","new":false},{"lobbyist":{"id":139167,"prefix":"mr","prefix_display":"MR.","first_name":"GREG","nickname":null,"middle_name":null,"last_name":"WALDEN","suffix":null,"suffix_display":null},"covered_position":"US Congressman 1999-2021","new":false},{"lobbyist":{"id":145638,"prefix":null,"prefix_display":null,"first_name":"SHAYNE","nickname":null,"middle_name":null,"last_name":"WOODS","suffix":null,"suffix_display":null},"covered_position":"Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep.Gus Bilirakis","new":false},{"lobbyist":{"id":150052,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MENDELSOHN","suffix":null,"suffix_display":null},"covered_position":"LD, Rep. Anna Eshoo; Congressional Liaison - FDA","new":false},{"lobbyist":{"id":140067,"prefix":null,"prefix_display":null,"first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"SCHMIDT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff, House Small Business Cmte","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140067,"prefix":null,"prefix_display":null,"first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"SCHMIDT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff, House Small Business Cmte","new":false},{"lobbyist":{"id":150052,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MENDELSOHN","suffix":null,"suffix_display":null},"covered_position":"LD, Rep. Anna Eshoo; Congressional Liaison - FDA","new":false},{"lobbyist":{"id":145638,"prefix":null,"prefix_display":null,"first_name":"SHAYNE","nickname":null,"middle_name":null,"last_name":"WOODS","suffix":null,"suffix_display":null},"covered_position":"Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep.Gus Bilirakis","new":false},{"lobbyist":{"id":139167,"prefix":"mr","prefix_display":"MR.","first_name":"GREG","nickname":null,"middle_name":null,"last_name":"WALDEN","suffix":null,"suffix_display":null},"covered_position":"US Congressman 1999-2021","new":false},{"lobbyist":{"id":149082,"prefix":null,"prefix_display":null,"first_name":"COLIN","nickname":null,"middle_name":null,"last_name":"BRAINARD","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Rep. Steve Watkins; Executive Director, Joint Economic Cmte.; Dep. Chief of Staff, Rep. Erik Paulsen; Dep. Chief of Staff, Rep. Lynn Jenkins; LC, Sen. Richard Burr","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149082,"prefix":null,"prefix_display":null,"first_name":"COLIN","nickname":null,"middle_name":null,"last_name":"BRAINARD","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Rep. Steve Watkins; Executive Director, Joint Economic Cmte.; Dep. Chief of Staff, Rep. Erik Paulsen; Dep. Chief of Staff, Rep. Lynn Jenkins; LC, Sen. Richard Burr","new":false},{"lobbyist":{"id":139167,"prefix":"mr","prefix_display":"MR.","first_name":"GREG","nickname":null,"middle_name":null,"last_name":"WALDEN","suffix":null,"suffix_display":null},"covered_position":"US Congressman 1999-2021","new":false},{"lobbyist":{"id":145638,"prefix":null,"prefix_display":null,"first_name":"SHAYNE","nickname":null,"middle_name":null,"last_name":"WOODS","suffix":null,"suffix_display":null},"covered_position":"Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep.Gus Bilirakis","new":false},{"lobbyist":{"id":150052,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"MENDELSOHN","suffix":null,"suffix_display":null},"covered_position":"LD, Rep. Anna Eshoo; Congressional Liaison - FDA","new":false},{"lobbyist":{"id":140067,"prefix":null,"prefix_display":null,"first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"SCHMIDT","suffix":null,"suffix_display":null},"covered_position":"Professional Staff, House Small Business Cmte","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in CL

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.